Literature DB >> 33432452

P-Selectin Glycoprotein Ligand-1 Deficiency Protects Against Aortic Aneurysm Formation Induced by DOCA Plus Salt.

Xianxian Wu1, Xing Liu1, Hang Yang2, Qianlong Chen2, Na Zhang3, Yuhan Li4, Xingchen Du4, Xue Liu1, Xiaoliang Jiang1, Yideng Jiang4, Zhou Zhou5, Zhiwei Yang6.   

Abstract

PURPOSE: P-selectin glycoprotein ligand-1 (PSGL-1) acts as a crucial regulator for the inflammatory cells infiltration by mediating the adhesion of leukocytes. However, the role of PSGL-1 in aortic aneurysm remains elusive. Here, we investigated the role of PSGL-1 in aortic aneurysm (AA) development.
METHODS: We first detected PSGL-1 expression in samples from aortic aneurysm patients and mouse AA models via western blotting, immunofluorescence, and flow cytometry, and then we used global PSGL-1 knockout mice and their wild type controls to establish an aortic aneurysm model induced by deoxycorticosterone acetate (DOCA) plus high salt (HS). The incidence, fatality rates, and the pathological changes of aortic aneurysm were analyzed in each group. The inflammation, adhesion molecules expression, and PSGL-1 mediated leukocyte-endothelial adhesion and their underlying mechanisms were explored further.
RESULTS: Increased PSGL-1 levels were observed in human and mouse aortic aneurysm, and on leukocytes of mice treated with DOCA+HS. PSGL-1 deficiency reduced the incidence and severity of aortic aneurysm significantly, as well as decreased elastin fragmentation, collagen accumulation, and smooth muscle cells degeneration. Mechanistically, the protective effect of PSGL-1 inhibition was mediated by the reduced adhesion molecules, and the subsequently reduced leukocyte-endothelial adhesion through the NF-κB pathway, which finally led to reduced inflammatory cells infiltration and decreased inflammatory factors expression.
CONCLUSION: PSGL-1 deficiency is protective against inflammatory cells migration and recruitment in the condition of AA through attenuation of leukocyte-endothelial adhesion. Inhibition of PSGL-1 may be a potential therapeutic target for the prevention and treatment of human AA.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aortic aneurysm; Inflammation; Leukocyte–endothelial adhesion; PSGL-1

Mesh:

Substances:

Year:  2021        PMID: 33432452     DOI: 10.1007/s10557-020-07135-1

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  40 in total

Review 1.  Pathophysiology and epidemiology of abdominal aortic aneurysms.

Authors:  Ian M Nordon; Robert J Hinchliffe; Ian M Loftus; Matt M Thompson
Journal:  Nat Rev Cardiol       Date:  2010-11-16       Impact factor: 32.419

2.  Segmental aortic stiffening contributes to experimental abdominal aortic aneurysm development.

Authors:  Uwe Raaz; Alexander M Zöllner; Isabel N Schellinger; Ryuji Toh; Futoshi Nakagami; Moritz Brandt; Fabian C Emrich; Yosuke Kayama; Suzanne Eken; Matti Adam; Lars Maegdefessel; Thomas Hertel; Alicia Deng; Ann Jagger; Michael Buerke; Ronald L Dalman; Joshua M Spin; Ellen Kuhl; Philip S Tsao
Journal:  Circulation       Date:  2015-04-22       Impact factor: 29.690

Review 3.  Abdominal aortic aneurysm: update on pathogenesis and medical treatments.

Authors:  Jonathan Golledge
Journal:  Nat Rev Cardiol       Date:  2019-04       Impact factor: 32.419

4.  A New Mouse Model for Introduction of Aortic Aneurysm by Implantation of Deoxycorticosterone Acetate Pellets or Aldosterone Infusion in the Presence of High Salt.

Authors:  Shu Liu; Ming C Gong; Zhenheng Guo
Journal:  Methods Mol Biol       Date:  2017

Review 5.  Updates of Recent Aortic Aneurysm Research.

Authors:  Frank M Davis; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

6.  H19 Induces Abdominal Aortic Aneurysm Development and Progression.

Authors:  Daniel Y Li; Albert Busch; Hong Jin; Ekaterina Chernogubova; Jaroslav Pelisek; Joakim Karlsson; Bengt Sennblad; Shengliang Liu; Shen Lao; Patrick Hofmann; Alexandra Bäcklund; Suzanne M Eken; Joy Roy; Per Eriksson; Brian Dacken; Deepak Ramanujam; Anne Dueck; Stefan Engelhardt; Reinier A Boon; Hans-Henning Eckstein; Joshua M Spin; Philip S Tsao; Lars Maegdefessel
Journal:  Circulation       Date:  2018-10-09       Impact factor: 29.690

Review 7.  Animal models in the research of abdominal aortic aneurysms development.

Authors:  N Patelis; D Moris; D Schizas; C Damaskos; D Perrea; C Bakoyiannis; T Liakakos; S Georgopoulos
Journal:  Physiol Res       Date:  2017-09-22       Impact factor: 1.881

Review 8.  Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update.

Authors:  Yi-Dong Wang; Zhen-Jie Liu; Jun Ren; Mei-Xiang Xiang
Journal:  Curr Vasc Pharmacol       Date:  2018-01-26       Impact factor: 2.719

9.  Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.

Authors:  Michael W Manning; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

10.  Tryptophan-Derived 3-Hydroxyanthranilic Acid Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice In Vivo.

Authors:  Qiongxin Wang; Ye Ding; Ping Song; Huaiping Zhu; Imoh Okon; Yang-Nan Ding; Hou-Zao Chen; De-Pei Liu; Ming-Hui Zou
Journal:  Circulation       Date:  2017-10-04       Impact factor: 29.690

View more
  2 in total

1.  Myeloid Mineralocorticoid Receptor Transcriptionally Regulates P-Selectin Glycoprotein Ligand-1 and Promotes Monocyte Trafficking and Atherosclerosis.

Authors:  Joshua J Man; Qing Lu; M Elizabeth Moss; Brigett Carvajal; Wendy Baur; Amanda E Garza; Roy Freeman; Marina Anastasiou; Njabulo Ngwenyama; Gail K Adler; Pilar Alcaide; Iris Z Jaffe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-10-07       Impact factor: 8.311

Review 2.  Targeting Platelet Activation in Abdominal Aortic Aneurysm: Current Knowledge and Perspectives.

Authors:  Weiliang Sun; Jingang Zheng; Yanxiang Gao
Journal:  Biomolecules       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.